Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/52917

言語	英語
著者	Ono, Ruriko Department of Obstetrics and Gynecology, Shimane University School of Medicine, 6938501 Izumo, Japan 中山健太郎中村康平山下瞳石橋朋佳石川雅子皆本敏子 Razia Sultana Department of Obstetrics and Gynecology, Shimane University School of Medicine, 6938501 Izumo, Japan 石川典由医学部 Otsuki, Yoshiro Department of Pathology, Seirei Hamamatsu General Hospital, 4308558 Hamamatsu, Japan Nakayama , Satoru Department of Obstetrics and Gynecology, Seirei Hamamatsu General Hospital, 4308558 Hamamatsu, Japan Onuma, Hideyuki Department of Pathology, Shimane Prefectural Central Hospital, 6938555 Izumo, Japan Kurioka, Hiroko Department of Obstetrics and Gynecology, Shimane Prefectural Central Hospital, 6938555 Izumo, Japan 京哲
主題	dedifferentiated endometrial carcinoma; mismatch repair deficient; microsatellite instability; endometrial cancer; immune checkpoint inhibitor
掲載誌名	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
巻	20
号	15
ISSN（Online）	1422-0067
発行日	2019-08
DOI	10.3390/ijms20153744
PubMed ID	31370215
出版者	MDPI
資料タイプ	学術雑誌論文
部局	医学部
備考	This research was funded by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (18K09229).